Literature DB >> 23340377

Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.

Deborah J Walder1, Carrie W Holtzman, Jean Addington, Kristin Cadenhead, Ming Tsuang, Barbara Cornblatt, Tyrone D Cannon, Thomas H McGlashan, Scott W Woods, Diana O Perkins, Larry J Seidman, Robert Heinssen, Elaine F Walker.   

Abstract

Sex differences in age at onset, symptomatology, clinical course (see Walker et al., 2002) and functional impairment (Thorup et al., 2007) are well documented in psychosis. The general pattern of findings is that males manifest an earlier onset, more severe symptoms and poorer prognosis than females. Limited studies examining individuals at clinical high-risk (CHR) suggest a similar pattern of sexual dimorphism (Holtzman et al., in review; Corcoran et al., 2011). As part of the North American Prodrome Longitudinal Study (NAPLS), the current study prospectively examined sexual dimorphisms in relationships among CHR symptoms, childhood (premorbid) academic and social functioning, baseline social and role functioning, and conversion to psychosis. Subjects included 276 (113F/163M) CHR NAPLS participants (ages 12-36.8years). All measures/criteria were assessed at baseline except conversion status, assessed at 6-month intervals up to 30months. Results show sex differences in baseline social and role functioning (though not in early childhood adjustment) that predate psychosis onset, with sexually dimorphic patterns in relation to prodromal symptoms. Among male (but not female) CHRs, baseline social functioning and positive prodromal symptoms predicted conversion. These findings help elucidate early course of vulnerability for, and maximally sensitive and specific etiological and prediction models of, psychosis conversion. Findings highlight the importance of considering sexually differentiated predictors of longitudinal course and outcome, in the context of emerging risk profiles. This may optimize efforts at early identification and individually tailored preventive interventions targeting different neurobiological markers/systems and/or cognitive-behavioral approaches. We speculate a contemporary, multidimensional model of psychosis risk that posits a role of sexually dimorphic, genetically linked influences that converge with a modulating role of gonadal hormones (see Walder et al., 2012) across a temporally sensitive neurodevelopmental trajectory towards conferring risk.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23340377      PMCID: PMC4045468          DOI: 10.1016/j.schres.2012.11.039

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  36 in total

1.  Refining the approaches to personality disorders.

Authors:  Larry J Siever
Journal:  CNS Spectr       Date:  2003-10       Impact factor: 3.790

2.  The schizophrenia prodrome revisited: a neurodevelopmental perspective.

Authors:  Barbara A Cornblatt; Todd Lencz; Christopher W Smith; Christoph U Correll; Andrea M Auther; Emilie Nakayama
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

3.  Risk factors for psychosis: impaired social and role functioning.

Authors:  Barbara A Cornblatt; Ricardo E Carrión; Jean Addington; Larry Seidman; Elaine F Walker; Tyronne D Cannon; Kristin S Cadenhead; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Scott W Woods; Robert Heinssen; Todd Lencz
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

Review 4.  The neurodevelopmental basis of sex differences in schizophrenia.

Authors:  D J Castle; R M Murray
Journal:  Psychol Med       Date:  1991-08       Impact factor: 7.723

Review 5.  The role of estrogens in schizophrenia gender differences.

Authors:  M V Seeman; M Lang
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

6.  Biological sex and menstrual cycle phase modulation of cortisol levels and psychiatric symptoms in a non-clinical sample of young adults.

Authors:  Deborah J Walder; Marta Statucka; Maureen P Daly; Kathleen Axen; Margalit Haber
Journal:  Psychiatry Res       Date:  2012-02-25       Impact factor: 3.222

7.  Measurement of premorbid adjustment in chronic schizophrenia.

Authors:  H E Cannon-Spoor; S G Potkin; R J Wyatt
Journal:  Schizophr Bull       Date:  1982       Impact factor: 9.306

8.  Gender differences in schizophrenia.

Authors:  M V Seeman
Journal:  Can J Psychiatry       Date:  1982-03       Impact factor: 4.356

9.  An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia.

Authors:  H Häfner; S Behrens; J De Vry; W F Gattaz
Journal:  Psychiatry Res       Date:  1991-08       Impact factor: 3.222

10.  Gender differences in affective, schizoaffective, and schizophrenic disorders.

Authors:  T H McGlashan; K K Bardenstein
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306

View more
  17 in total

1.  Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.

Authors:  G Brucato; M D Masucci; L Y Arndt; S Ben-David; T Colibazzi; C M Corcoran; A H Crumbley; F M Crump; K E Gill; D Kimhy; A Lister; S A Schobel; L H Yang; J A Lieberman; R R Girgis
Journal:  Psychol Med       Date:  2017-03-02       Impact factor: 7.723

2.  Fetal exposure to maternal stress and risk for schizophrenia spectrum disorders among offspring: Differential influences of fetal sex.

Authors:  Anna M Fineberg; Lauren M Ellman; Catherine A Schaefer; Seth D Maxwell; Ling Shen; Nashid H Chaudhury; Aundrea L Cook; Michaeline A Bresnahan; Ezra S Susser; Alan S Brown
Journal:  Psychiatry Res       Date:  2015-12-18       Impact factor: 3.222

Review 3.  Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease.

Authors:  Devanand S Manoli; Jessica Tollkuhn
Journal:  Ann N Y Acad Sci       Date:  2018-01-24       Impact factor: 5.691

4.  Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.

Authors:  Ariel Schvarcz; Carrie E Bearden
Journal:  Curr Behav Neurosci Rep       Date:  2015-01-18

5.  The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.

Authors:  R E Carrión; D McLaughlin; A M Auther; R Olsen; C U Correll; B A Cornblatt
Journal:  Psychol Med       Date:  2015-07-14       Impact factor: 7.723

6.  The subjective experience of youths at clinically high risk of psychosis: a qualitative study.

Authors:  Shelly Ben-David; Michael L Birnbaum; Mara E Eilenberg; Jordan E DeVylder; Kelly E Gill; Jessica Schienle; Neyra Azimov; Ellen P Lukens; Larry Davidson; Cheryl M Corcoran
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

7.  Symptom trajectories and psychosis onset in a clinical high-risk cohort: the relevance of subthreshold thought disorder.

Authors:  Jordan E DeVylder; Felix M Muchomba; Kelly E Gill; Shelly Ben-David; Deborah J Walder; Dolores Malaspina; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2014-09-19       Impact factor: 4.939

8.  Sex differences in morning cortisol in youth at ultra-high-risk for psychosis.

Authors:  Emily E Carol; Robert L Spencer; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2016-06-21       Impact factor: 4.905

9.  Assessing depression in youth at clinical high risk for psychosis: a comparison of three measures.

Authors:  Jordan E DeVylder; Lawrence H Yang; Jill M Harkavy-Friedman; Neyra Azimov; Deborah J Walder; Cheryl M Corcoran
Journal:  Psychiatry Res       Date:  2013-12-10       Impact factor: 3.222

10.  Patterns of premorbid functioning in individuals at clinical high risk of psychosis.

Authors:  Kristina Lyngberg; Lisa Buchy; Lu Liu; Diana Perkins; Scott Woods; Jean Addington
Journal:  Schizophr Res       Date:  2015-11-14       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.